Huntington National Bank Teva Pharmaceutical Industries LTD Transaction History

Huntington National Bank

  • $13.5 Billion
  • Q3 2024

A detailed history of Huntington National Bank transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Huntington National Bank holds 3,563 shares of TEVA stock, worth $62,174. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,563
Previous 3,663 2.73%
Holding current value
$62,174
Previous $59,000 8.47%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
SELL
$15.81 - $18.96 $1,581 - $1,896
-100 Reduced 2.73%
3,563 $64,000
Q2 2024

Aug 08, 2024
BUY
$12.78 - $17.4 $332 - $452
26 Added 0.71%
3,663 $59,000
Q4 2023

Feb 07, 2024
SELL
$8.12 - $10.63 $64 - $85
-8 Reduced 0.22%
3,637 $37,000
Q2 2023

Aug 11, 2023
SELL
$7.2 - $9.47 $3,772 - $4,962
-524 Reduced 12.57%
3,645 $27,000
Q1 2023

May 10, 2023
BUY
$8.36 - $11.37 $4,447 - $6,048
532 Added 14.63%
4,169 $36,000
Q3 2022

Nov 07, 2022
BUY
$6.86 - $11.95 $246 - $430
36 Added 1.0%
3,637 $29,000
Q1 2022

May 10, 2022
SELL
$7.33 - $9.39 $9,155 - $11,728
-1,249 Reduced 25.75%
3,601 $33,000
Q4 2021

Jan 21, 2022
BUY
$7.9 - $10.19 $20,547 - $26,504
2,601 Added 115.65%
4,850 $38,000
Q3 2021

Oct 28, 2021
BUY
$8.38 - $10.18 $8,380 - $10,180
1,000 Added 80.06%
2,249 $22,000
Q2 2021

Jul 30, 2021
SELL
$9.9 - $11.56 $9,900 - $11,560
-1,000 Reduced 44.46%
1,249 $12,000
Q4 2020

Jan 11, 2021
SELL
$8.61 - $11.04 $1,937 - $2,484
-225 Reduced 9.09%
2,249 $22,000
Q3 2020

Oct 30, 2020
BUY
$8.57 - $12.69 $1,491 - $2,208
174 Added 7.57%
2,474 $22,000
Q1 2020

Apr 27, 2020
SELL
$6.69 - $13.45 $15,547 - $31,257
-2,324 Reduced 50.26%
2,300 $20,000
Q4 2019

Jan 17, 2020
BUY
$6.53 - $10.72 $8,449 - $13,871
1,294 Added 38.86%
4,624 $45,000
Q3 2019

Nov 01, 2019
SELL
$6.16 - $9.6 $1,139 - $1,776
-185 Reduced 5.26%
3,330 $23,000
Q2 2019

Jul 23, 2019
SELL
$8.12 - $15.72 $1,339 - $2,593
-165 Reduced 4.48%
3,515 $33,000
Q1 2019

Apr 09, 2019
BUY
$15.58 - $20.01 $26,875 - $34,517
1,725 Added 88.24%
3,680 $57,000
Q4 2018

Jan 28, 2019
SELL
$14.59 - $23.84 $12,518 - $20,454
-858 Reduced 30.5%
1,955 $30,000
Q3 2018

Oct 18, 2018
SELL
$21.06 - $25.65 $11,119 - $13,543
-528 Reduced 15.8%
2,813 $61,000
Q2 2018

Jul 19, 2018
SELL
$16.77 - $24.71 $21,633 - $31,875
-1,290 Reduced 27.86%
3,341 $82,000
Q1 2018

Apr 30, 2018
SELL
$16.68 - $22.07 $18,648 - $24,674
-1,118 Reduced 19.45%
4,631 $79,000
Q4 2017

Feb 02, 2018
SELL
$11.23 - $19.1 $62,955 - $107,074
-5,606 Reduced 49.37%
5,749 $109,000
Q3 2017

Oct 24, 2017
BUY
$15.41 - $32.17 $174,980 - $365,290
11,355
11,355 $199,000

Others Institutions Holding TEVA

# of Institutions
626
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email